Data / Form D filings / Alto Neuroscience, Inc.
Alto Neuroscience, Inc.: Form D filings
Alto Neuroscience, Inc., a pharmaceuticals company in Mountain View, CA, filed 5 Form D notices with the SEC between 2023 and 2025. The latest, on October 27, 2025, reports $50 million sold of a $50 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 CASTRO STREET, SUITE 450, Mountain View, CA, 94041
- Phone
- (650) 200-0412
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1999480
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | New notice | $49,999,533 | $49,999,533 | 7 | Oct 21, 2025 | sec.gov | |
| Nov 27, 2023 | New notice | $45,000,223 | $45,000,223 | 16 | Nov 20, 2023 | sec.gov | |
| Nov 27, 2023 | New notice | $59,261,815 | $59,261,815 | 26 | Apr 6, 2022 | sec.gov | |
| Nov 27, 2023 | New notice | $31,887,138 | $31,887,138 | 19 | May 3, 2021 | sec.gov | |
| Nov 27, 2023 | New notice | $7,722,217 | $7,722,217 | 16 | Sep 13, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adam Savitz | Executive Officer | |
| Amit Etkin | Executive Officer, Director | |
| Nicholas C. Smith | Executive Officer | |
| Gwill C. York | Director | |
| Husseini Nixon Manji | Director | |
| Christopher Nixon Cox | Director | |
| Raymond Nixon Sanchez | Director | |
| Andrew Nixon Dreyfus | Director | |
| Michael Hanley | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Oct 27, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alto Neuroscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.